Rehmann Capital Advisory Group’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.66M Buy
9,838
+623
+7% +$186K 0.14% 115
2025
Q4
$3.04M Buy
9,215
+149
+2% +$50.5K 0.16% 101
2025
Q3
$3.14M Buy
9,066
+424
+5% +$128K 0.17% 96
2025
Q2
$2.7M Buy
8,642
+2,897
+50% +$1.11M 0.16% 99
2025
Q1
$3.01M Sell
5,745
-11
-0.2% -$5.62K 0.19% 96
2024
Q4
$2.91M Buy
5,756
+137
+2% +$77.8K 0.18% 96
2024
Q3
$3.29M Sell
5,619
-102
-2% -$57.7K 0.21% 89
2024
Q2
$2.91M Sell
5,721
-209
-4% -$102K 0.21% 92
2024
Q1
$2.93M Buy
5,930
+51
+0.9% +$25.9K 0.22% 87
2023
Q4
$3.1M Sell
5,879
-33
-0.6% -$17.6K 0.26% 75
2023
Q3
$2.98M Sell
5,912
-148
-2% -$72.8K 0.28% 70
2023
Q2
$2.91M Sell
6,060
-108
-2% -$52.8K 0.26% 75
2023
Q1
$2.91M Sell
6,168
-121
-2% -$58.4K 0.27% 76
2022
Q4
$3.33M Sell
6,289
-7
-0.1% -$3.71K 0.34% 61
2022
Q3
$3.18M Buy
6,296
+275
+5% +$145K 0.35% 54
2022
Q2
$3.09M Buy
6,021
+44
+0.7% +$22.1K 0.34% 59
2022
Q1
$3.05M Sell
5,977
-28
-0.5% -$13.5K 0.29% 68
2021
Q4
$3.02M Sell
6,005
-43
-0.7% -$19.5K 0.28% 67
2021
Q3
$2.37M Sell
6,048
-136
-2% -$56.3K 0.22% 78
2021
Q2
$2.49M Buy
6,184
+52
+0.8% +$20.7K 0.24% 74
2021
Q1
$2.28M Buy
6,132
+269
+5% +$93.2K 0.23% 77
2020
Q4
$2.06M Sell
5,863
-130
-2% -$43.6K 0.23% 80
2020
Q3
$1.87M Sell
5,993
-141
-2% -$43.3K 0.24% 82
2020
Q2
$1.81M Buy
6,134
+371
+6% +$106K 0.25% 79
2020
Q1
$1.44M Buy
+5,763
New +$1.59M 0.23% 80
2019
Q3
$1.42M Buy
6,525
+108
+2% +$26.1K 0.17% 63
2019
Q2
$1.57M Sell
6,417
-155
-2% -$37.3K 0.19% 89
2019
Q1
$1.63M Buy
6,572
+156
+2% +$39.8K 0.22% 74
2018
Q4
$1.6M Sell
6,416
-66
-1% -$17.4K 0.24% 49
2018
Q3
$1.72M Sell
6,482
-98
-1% -$25.5K 0.24% 73
2018
Q2
$1.61M Sell
6,580
-1,012
-13% -$243K 0.23% 77
2018
Q1
$1.63M Buy
7,592
+146
+2% +$33.3K 0.25% 76
2017
Q4
$1.64M Sell
7,446
-150
-2% -$31.8K 0.28% 73
2017
Q3
$1.49M Sell
7,596
-446
-6% -$86.2K 0.27% 79
2017
Q2
$1.49M Sell
8,042
-112
-1% -$19.6K 0.28% 73
2017
Q1
$1.34M Buy
8,154
+151
+2% +$24.7K 0.22% 93
2016
Q4
$1.28M Buy
8,003
+16
+0.2% +$2.39K 0.23% 89
2016
Q3
$1.12M Sell
7,987
-1,259
-14% -$176K 0.22% 95
2016
Q2
$1.31M Sell
9,246
-4
-0% -$533 0.24% 86
2016
Q1
$1.19M Buy
9,250
+472
+5% +$55.8K 0.23% 91
2015
Q4
$1.03M Buy
8,778
+217
+3% +$25.4K 0.22% 91
2015
Q3
$993K Buy
8,561
+1,361
+19% +$163K 0.22% 88
2015
Q2
$878K Sell
7,200
-364
-5% -$43.1K 0.2% 98
2015
Q1
$895K Buy
7,564
+628
+9% +$69.7K 0.2% 98
2014
Q4
$701K Buy
6,936
+1,534
+28% +$145K 0.16% 122
2014
Q3
$466K Sell
5,402
-19
-0.4% -$1.61K 0.11% 157
2014
Q2
$443K Buy
5,421
+443
+9% +$34.9K 0.11% 161
2014
Q1
$408K Sell
4,978
-515
-9% -$38.8K 0.11% 159
2013
Q4
$414K Buy
5,493
+407
+8% +$29.2K 0.13% 159
2013
Q3
$364K Sell
5,086
-493
-9% -$35.3K 0.12% 161
2013
Q2
$365K Buy
+5,579
New +$347K 0.13% 149

Other funds holding UNH

Rehmann Capital Advisory Group's UNH Position: Q1 2026 in Review

Rehmann Capital Advisory Group increased its UnitedHealth (UNH) stake by 6.8% in Q1 2026, buying an estimated $186K and bringing the position to 9,838 shares worth $2.66M. The position accounts for 0.14% of the portfolio, ranked #115.

Rehmann Capital Advisory Group first reported a position in UNH in Q2 2013 and has held it in 51 quarters since. The position peaked at $3.33M in Q4 2022. 3,024 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Rehmann Capital Advisory Group held 9,838 shares of UnitedHealth worth $2.66M as of Q1 2026.
  • Rehmann Capital Advisory Group bought 623 UnitedHealth shares in Q1 2026, an estimated $186K.
  • UnitedHealth made up 0.14% of Rehmann Capital Advisory Group's portfolio in Q1 2026, its #115 holding.
  • Rehmann Capital Advisory Group first reported a position in UnitedHealth in Q2 2013 and has held it in 51 quarters since.
  • Rehmann Capital Advisory Group's UnitedHealth position peaked at $3.33M in Q4 2022.
  • 3,024 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.